admin – Page 2876 – Get News Story

Women in Manufacturing NY Hosts “Powering the Future” Summit at Brooklyn Navy Yard

Image courtesy of 90 Plus Media Group.

On June 13, 2025, Women in Manufacturing New York (WIMNY), in collaboration with Community Architects, hosted a high-impact summit titled “Powering the Future: Workforce, Innovation, and Manufacturing” at Newlab, located in the heart of the Brooklyn Navy Yard. The convening brought together manufacturers, workforce leaders, educators, public officials, and students to explore how cross-sector partnerships can strengthen career-connected learning and ensure inclusive access to the jobs of tomorrow.

The day began with networking and vendor engagement, followed by opening remarks from Dominique McDuffie-Turner, Chair of WIMNY and CEO of Community Architects, and Brooklyn Borough President Antonio Reynoso, both of whom emphasized the critical role of innovation and equity in shaping New York’s workforce future.

Special recognition was given to the event’s generous sponsors—Grant Associates, MSL Global Express, Thomas, and Newlab—for their leadership in supporting workforce advancement across sectors.

Emily Gonthier, Chief of Staff at Newlab, welcomed attendees with remarks highlighting Newlab’s collaborative ecosystem that bridges technology, entrepreneurship, and manufacturing to foster sustainable and equitable growth.

Image courtesy of Renaldo Pelerin.

Industry Engagement and Youth Exposure

The program featured insightful presentations from:

Allendale Machinery Systems
Pine Bush High School
Maritime Industrial Base (MIB)
Build Submarines
U.S. Navy Talent Pipeline Program

With students from Brooklyn Technical High School in attendance, the summit created unique opportunities for exposure to real-world career paths in advanced manufacturing, defense, and innovation.

The event was organized with support from key industry collaborators, including Allendale Machinery Systems and the Brooklyn Chamber of Commerce, both of which are actively committed to strengthening New York’s manufacturing and innovation workforce pipeline.

AI and the Future Workforce

The summit featured a panel titled “Bridging the AI Workforce Gap: Co-Creating Pathways for an Inclusive Future,” exploring how artificial intelligence is reshaping industries and the urgent need to build equitable strategies for upskilling and inclusion.

Moderated by Marlon Kitenge, Executive Officer at Nanotronics, the panel included:

Gabriel Noriega, Marine Veteran and CNC Operations Manager, MAC Products
Professor Veronica Manlow, Brooklyn College
Lindy P. Crescitelli, Co-founder, Institute for International Leadership, Nonviolence & Service: Learn Lead Serve Inc.

The discussion focused on the importance of partnerships between industry, education, and community organizations to ensure all communities have access to emerging opportunities, particularly in underrepresented and historically marginalized populations.

Image courtesy of 90 Plus Media Group.

Tours, Investment, and Closing Remarks

Following the panel, attendees participated in guided tours of the Newlab facility and surrounding Brooklyn Navy Yard ecosystem. Attendees were divided into groups and led through curated experiences hosted by innovative companies including Nanotronics, offering a behind-the-scenes view into the technologies shaping the future of manufacturing, automation, and design.

The day concluded with closing remarks from Dominique McDuffie-Turner and Lindsay Greene, President and CEO of the Brooklyn Navy Yard Development Corporation (BNYDC). In a powerful moment of commitment to workforce investment, the Gene Haas Foundation presented a grant check for $18,750 to the Brooklyn Navy Yard Development Corporation in support of continued talent development and manufacturing training initiatives.

In addition to the main programming, select guests were invited to participate in VIP tours of Nanotronics and other companies operating within the Yard, gaining insight into Brooklyn’s diverse and future-focused industrial ecosystem.

Statements from Leadership and Partners

Dominique McDuffie-Turner, Chair of Women in Manufacturing NY and CEO of Community Architects:

“This event represents what’s possible when we break down silos and build intentionally—across industry, education, and community. From students exploring their future to legacy manufacturers adapting for tomorrow, Powering the Future was more than a theme—it’s our collective responsibility.”

Image courtesy of 90 Plus Media Group.

Antonio Reynoso, Brooklyn Borough President said, “Manufacturing has deep roots in Brooklyn. As the son of Dominican immigrants, whose mother found a path out of poverty through her job in manufacturing, I know this personally,” said Brooklyn Borough President Antonio Reynoso. “For too long, however, this city has deprioritized and disinvested in the manufacturing jobs that are transformational, particularly for immigrants and people without college degrees. Championing equity and innovation, Women in Manufacturing understands the powerful opportunities built in our manufacturing sector and is fighting to preserve, expand, and increase access to the sector. I am so grateful for their work and the chance to join the organization for this incredible event.”

Ming Chen, MSL Global Express added “It was incredible to see so many passionate leaders, students, and industry partners come together with a shared vision of empowering the next generation. A special highlight was welcoming the talented students from Brooklyn Tech High School — their curiosity, ambition, and thoughtful questions reminded us why it’s so important to invest in education and mentorship.

MSL was honored to contribute to the conversation, speaking on the importance of education, community, and creating opportunities for those coming after us. The positive energy in the room was contagious, and it’s clear this is just the beginning of what we can build together.

Thank you to WIM and all the incredible attendees for making this event a meaningful platform for connection, learning, and progress. Let’s keep this momentum going!”

Emily Gonthier, Chief of Staff, Newlab, said, “At Newlab, we believe the future must be built in partnership—with diverse voices, visionary thinking, and real access. Hosting this summit affirms our commitment to building a workforce ecosystem grounded in inclusion and innovation.”

Statement from Build Submarines and the Maritime Industrial Base (MIB): “Build Submarines and MIB are proud to support events that elevate workforce potential and spotlight pathways into essential trades. Collaboration with organizations like WIMNY ensures that the next generation understands their power, value, and potential.”

Image courtesy of 90 Plus Media Group.

About Women in Manufacturing (WIM)

Women in Manufacturing (WIM) is a national trade association dedicated to supporting, promoting, and inspiring women who have chosen careers in manufacturing. Through professional development, mentorship, workforce programming, and advocacy, WIM works to ensure women not only enter the industry but lead and thrive within it. The WIM New York Chapter (WIMNY) serves as a regional hub, driving inclusive growth and advancing the next generation of women leaders in manufacturing, innovation, and the skilled trades across the state. www.Womeninmanufacturing.org

Take a sneak peak into the WIM Event at NewLab on YouTube.

About Community Architects

Community Architects is a workforce innovation and strategy firm dedicated to building bridges between industry, education, and underserved communities. Through programs such as Beauty in STEAM, the STEAM Skills Clinic, and convenings like Powering the Future, Community Architects leads with impact to reimagine what career-connected learning can look like in the 21st century.

To learn more, visit the official website, www.CommunityArchitects.co.

About the Brooklyn Navy Yard Development Corporation

The Brooklyn Navy Yard Development Corporation (BNYDC) is a not-for-profit corporation that serves as the real estate developer and property manager of the Yard on behalf of its owner, the City of New York. BNYDC’s mission is to fuel New York City’s economic vitality by creating and preserving quality jobs, growing the City’s modern industrial sector and its businesses, and connecting the local community with the economic opportunity and resources of the Yard. BNYDC’s vision is a vibrant and dense, modern manufacturing community where businesses are provided the stability needed to invest, grow, and thrive and where diverse candidates can attain quality jobs.

Website: brooklynnavyyard.org/

For press inquiries or additional materials, please contact info@communityarchitects.co

Media Contact
Company Name: Community Architects
Contact Person: Virginia Jean, CMO
Email: Send Email
City: Brooklyn
State: New York
Country: United States
Website: www.Communityarchitects.co

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Women in Manufacturing NY Hosts “Powering the Future” Summit at Brooklyn Navy Yard

New Release Moving In Purpose Offers a Grounded, Faith-Driven Path to Spiritual Renewal and Personal Clarity

“Louise S. Sherman”

Moving In Purpose, a deeply introspective and spiritually anchored work by Louise S. Sherman, has been released through Hemingway Publishers. This timely book offers an honest and revelatory exploration of spiritual obedience, emotional healing, and living intentionally through faith.

Drawing from biblical scripture and lived experience, Moving In Purpose presents a twelve-chapter journey that addresses the complexities of modern Christian life. Through themes such as Trusting the Process, Yielding to No, Tithing, Seasons, and Purpose Confirmation, the book walks readers through the layered process of spiritual transformation grounded not in perfection, but in surrender and clarity of purpose.

A Grounded Response to Spiritual Distraction and Cultural Overload

In an era defined by hyper connectivity, burnout, and emotional fatigue, Moving In Purpose reorients attention toward quiet disciplines such as prayer, rest, and fellowship. Chapters like Find Rest and Beware of Distractions speak candidly to the emotional toll of modern information overload, while advocating for deliberate communion with God through stillness, spiritual consistency, and emotional honesty.

A Faith-Based Chronicle of Real-World Challenges

Sherman’s experiences from a life-altering diabetes diagnosis to international mission trips and personal career trials serve as case studies in divine alignment and spiritual resilience. The writing does not idealize struggle but reframes adversity through a scriptural lens, particularly referencing texts from Paul, David, Jeremiah, and Matthew. The tone remains humble, firm, and theologically sound throughout.

Highlights from the Book

Chapter: “Trust The Process” – A spiritual and physical journey that explores healing, obedience, and radical life shifts after a medical emergency.
Chapter: “Seasons” – A reflection on the duality of spiritual abundance and drought, emphasizing God’s timing through hardship.
Chapter: “Purpose Confirmation” – A final affirmation of walking within God’s will, even when the outcome diverges from initial dreams.
Chapter: “The Value In Fellowship” – A case for deeper engagement with the body of Christ outside traditional worship settings.

About the Author

Louise S. Sherman is a corporate risk professional, missionary, and spiritual mentor whose work centers on encouraging faith-led transformation through testimony and obedience. Her experiences span international missions, corporate leadership, and Christian mentorship, reflecting a unique ability to unite professional life with spiritual purpose.

Amazon Click Here

Media Contact
Company Name: Hemingway Publishers
Contact Person: Louise S. Sherman
Email: Send Email
Phone: +18884066480
Country: United States
Website: https://hemingwaypublishers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Release Moving In Purpose Offers a Grounded, Faith-Driven Path to Spiritual Renewal and Personal Clarity

The Fibro Guy Reports Breakthrough Success with Online Programme for Chronic Pain and Hypermobility

The Fibro Guy’s new virtual rehabilitation programme is changing the lives of chronic pain and hypermobility sufferers worldwide, enabling dramatic improvements without leaving home.

The Fibro Guy, a UK-based leader in chronic pain and hypermobility rehabilitation, has announced transformative results from its newly launched online programme. Since transitioning to a fully virtual model in 2024, the company has helped hundreds of global clients improve their quality of life, many achieving outcomes they had not experienced in years of traditional treatment.

The innovative online programme uses a person-centred, evidence-based approach that blends movement therapy, education, and holistic strategies. Clients benefit from comprehensive, ongoing support that includes two to three tailored sessions each week, access to counselling services, and a dedicated client portal containing a range of health and lifestyle resources.

“Too much time has been spent focusing on the wrong areas of rehab in the past. So, our approach is very simply, focus on the right factors,” said Adam Foster, Founder of The Fibro Guy.

The outcomes of this approach have been remarkable. Clients who once relied on wheelchairs or were bed-bound are now walking, swimming, and even returning to activities like horse riding. Some have reported improvements in joint stability within six weeks that far exceed the gains made during years of conventional physiotherapy.

Unlike standard physiotherapy services, The Fibro Guy’s programme offers unlimited support without time restrictions. This ensures that clients never feel isolated during their recovery journey and can progress at a pace that suits their needs.

The Fibro Guy’s online success underlines the effectiveness of virtual rehabilitation for complex conditions, providing accessible solutions for people regardless of location. The approach has already gained traction across the UK, Europe, North America, and beyond.

About The Fibro Guy

The Fibro Guy provides specialist rehabilitation for individuals living with chronic pain and hypermobility syndromes. Using tailored programmes that integrate education, movement, and psychological support, the company empowers clients to regain control of their health and restore independence.

Media Contact
Company Name: The Fibro Guy Ltd
Contact Person: Adam Foster
Email: Send Email
Country: United Kingdom
Website: https://www.thefibroguy.com/

Kitchen Remodeling in Maryland Firm Surpasses 4,500 Projects

Southern Maryland Kitchen, Bath, Floors & Design has completed over 4,500 kitchen, bathroom, basement, cabinetry, and flooring projects, reinforcing its position as one of the most trusted remodeling companies in Southern Maryland.

California, MD – June 25, 2025 – Southern Maryland Kitchen, Bath, Floors & Design, a full-service residential remodeling firm based in California, Maryland, has reached a significant milestone with over 4,500 completed projects across kitchen, bathroom, basement, custom cabinetry, and flooring services. This achievement underscores the company’s reputation as a top choice for kitchen remodeling in Maryland, reflecting decades of steady growth, client trust, and service to homeowners throughout Calvert, Charles, and St. Mary’s Counties.

The company’s project portfolio represents not just volume, but a consistent track record of professionalism, craftsmanship, and long-term customer satisfaction. For clients in Southern Maryland, remodeling a home is a personal investment. Hiring an experienced firm with local knowledge and a deep understanding of county permitting, regional design preferences, and quality craftsmanship provides significant peace of mind. Southern Maryland Kitchen, Bath, Floors & Design stands out from other regional providers by remaining focused on the needs of the local community, offering in-depth guidance from planning to project completion. Every remodeling plan is tailored through collaboration between licensed designers, dedicated project managers, and skilled installers who understand the technical aspects required for quality construction.

This depth of experience is especially valuable to homeowners seeking kitchen remodeling in Maryland. A well-designed kitchen renovation must strike a balance between function, flow, and style to deliver lasting results. With thousands of successful remodels under their belt, the team has refined a process that prioritizes communication, clear timelines, and transparent budgeting, while aligning the finished product with each client’s lifestyle needs. Whether homeowners are upgrading for modern convenience, adapting to changing family needs, or preparing a home for resale, the firm offers specialized solutions based on years of proven success.

With over 4,500 renovations completed, Southern Maryland Kitchen, Bath, Floors & Design continues to be a top choice for homeowners seeking reliable and high-quality remodeling.

The company operates from its corporate office at 23415 Three Notch Road #2025, California, MD 20619. To schedule a consultation, call (301) 241-0702.

For more information or to explore kitchen and remodeling services, visit https://www.somdkitchenbathfloors.com/.

Media Contact
Company Name: Southern Maryland Kitchen Bath Floors & Design
Contact Person: Carole G. Kress
Email: Send Email
Phone: +1 (301) 241-0702
Address:23064 Three Notch Rd
City: California
State: MD
Country: United States
Website: https://www.somdkitchenbathfloors.com/

Maryland Remodeling Firm Earns State’s Only Living In Place Certification

Southern Maryland Kitchen, Bath, Floors & Design is now the only remodeling firm in Maryland certified by the Living In Place Institute™, enhancing safety and accessibility standards in kitchen remodeling design for homeowners throughout the state.

California, MD – June 25, 2025 – Southern Maryland Kitchen, Bath, Floors & Design, a full-service remodeling company based in California, Maryland, has been officially recognized as the only home remodeling firm in the state certified by the Living In Place Institute™. This unique accreditation furthers the company’s leadership in kitchen remodeling in Maryland by integrating nationally recognized safety and accessibility standards into every aspect of its remodeling services. The certification reinforces the firm’s dedication to delivering home renovation solutions that not only elevate appearance but also improve functionality, safety, and long-term value.

The Living In Place Institute™ provides training and credentialing for design professionals who implement best practices that support homeowners of all ages and abilities. This certification encompasses thoughtful consideration of appliance placement, lighting design, surface materials, entryways, and circulation spaces. Becoming Living In Place certified signifies that a design professional is qualified to create residential environments that are safer and more accommodating without compromising style or customization. For Maryland homeowners seeking experienced kitchen remodeling services, this certification provides an added layer of trust and assurance throughout the renovation process. Whether the project addresses multigenerational living needs, mobility accommodations, or aging-in-place goals, the company applies proven methods to upgrade the home in ways that are both beautiful and practical.

The decision to pursue certification reflects the company’s commitment to industry leadership and client care, as Southern Maryland Kitchen, Bath, Floors & Design is the only Living In Place-certified remodeling team in Maryland. Through knowledge-based planning, personalized consulting, and high-quality execution, the company brings unmatched value to its clients. The firm continues to help homeowners create safer and more efficient home environments while meeting evolving needs. By offering this advanced level of service, the company stands as a trusted partner to families seeking kitchen remodeling in Maryland.

Southern Maryland Kitchen, Bath, Floors & Design is located at 23415 Three Notch Road #2025, California, MD 20619. To speak with a design specialist or request a consultation, call (301) 241-0702. For more information about remodeling services, please visit https://www.somdkitchenbathfloors.com/.

Dream Fly Tours Expands Beyond Desert Safari to Offer Full Range of Dubai Activities

Dream Fly Tours, already a well known name in the UAE tourism industry for providing top rated Desert Safari in Dubai, has now officially expanded its offerings to include a complete selection of Dubai activities, including Dhow Cruises, Dubai attraction tickets, and comprehensive tourism services across the UAE.

With thousands of satisfied customers and a strong reputation for reliable service, Dream Fly Tours is now moving toward becoming one of the leading tourism companies in the UAE, delivering everything a visitor needs to explore Dubai in style.

Trusted Tourism Brand in Dubai

Over the years, Dream Fly Tours has gained recognition for its exceptional Deluxe Desert Safari Dubai packages, known for professional service, affordable pricing, and high customer satisfaction. Backed by thousands of happy tourists, the company has earned its place as a trusted name in the tourism sector.

Now, with the growing demand for all in one travel solutions in Dubai, the company is stepping into a larger role by offering a full portfolio of tourism experiences under one brand.

New Services Now Available

Dream Fly Tour’s newly launched services include:

– Dhow Cruise Dubai Marina and Creek Dinner Cruises

– Dubai attraction tickets to top spots like Burj Khalifa, Museum of the Future, Dubai Frame, Global Village, and more

– Luxury yacht cruises, sightseeing tours, and customized city excursions

– Adventure and family friendly experiences, such as jet skiing, quad biking, and theme parks

– Hotel bookings, airport transfers, and travel consultation

This expansion makes Dream Fly Tours a one stop travel platform for all tourists visiting Dubai, whether for business, leisure, family trips, or special occasions.

Simplifying the Dubai Travel Experience

Through its user friendly website, Dream Fly Tours allows travelers to easily:

– Browse and compare experiences

– Book Dhow Cruise dinners, Desert Safari Dubai and attraction tickets

– Access special seasonal promotions and group offers

– Receive instant booking confirmation and quick customer support

Whether someone is planning a romantic Dhow Cruise, an adrenaline filled desert adventure, or a day of sightseeing in the city, the platform is now designed to cater to every traveler’s needs with ease.

Strong Vision for Future Growth

A company spokesperson commented:

“We’ve always been known for our Desert Safari in Dubai, but the future of travel is convenience and experience. That’s why we’ve decided to bring all Dubai activities under one trusted brand. Our mission is to make exploring Dubai easy, enjoyable, and affordable for everyone. With thousands of happy customers already behind us, we are confident in becoming a top tourism industry leader in the UAE.”

The expansion aligns with Dubai’s tourism vision to attract more than 25 million international visitors annually by offering them seamless and high quality experiences through reliable local partners.

About Dream Fly Tours

Dream Fly Tours is a Dubai based tourism company, renowned for delivering exceptional Desert Safari Dubai adventures and now offering a full suite of tourism services across the UAE. With a dedication to quality, customer care, and affordable packages, the company continues to grow as a major player in the region’s travel and tourism market.

Media Contact
Company Name: Dream Fly Tourism LLC
Contact Person: Junaid
Email: Send Email
Phone: +971502746000
Country: United Arab Emirates
Website: https://dreamflytours.com/

First Fertility PGS Center Limited Launches Indian Lounge

The Indian Lounge will welcome international patients from India seeking fertility treatment in Thailand.

First Fertility PGS Center Limited (“FFC Clinic”), has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions to capitalize on Thailand’s rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care because its combination of world-class medical infrastructure, cost-effective treatments, and regulatory framework that permits comprehensive fertility services including the one-year Medical Visa allows for multiple entries and a stay of up to 90 days per visit for medical tourists.

First Fertility PGS Center Limited, NASDAQ-listed healthcare group and one of Thailand’s most established and trusted fertility clinics, has officially launched its new Indian Lounge. This dedicated space has been designed to offer comfort, cultural familiarity, and personalized service for Indian patients seeking high-quality fertility care.

With over a decade of experience in reproductive medicine, First Fertility PGS Center has helped thousands of couples from around the world achieve their dream of parenthood. This year marks a significant milestone as the clinic expands its services to better serve the Indian market, one of its fastest-growing patient groups.

The newly introduced Indian Lounge provides a calm, private space where Indian patients can feel at ease. It also acts as a hub for multilingual assistance, with a dedicated Hindi-speaking team now available to guide patients throughout every step of their fertility journey, from consultation to treatment and follow-up care.

To celebrate the 10 years anniversary, First Fertility PGS Center Limited (“FFC Clinic”) is launching exclusive fertility packages tailored specifically for Indian patients for a limited time only. These special offers include customized pricing, priority booking, and full-service support – including travel coordination, accommodation recommendations, and cultural considerations and reduced price, all to make the experience as smooth, convenient and stress-free as possible.

Located in central Bangkok, First Fertility PGS Center is internationally recognized for its high success rates, advanced technology, and holistic, patient-first approach. The clinic specializes in IVF, ICSI, PGS/PGT-A, PESA/TESE, and a wide range of infertility treatments backed by world-class expertise.

For more information, please visit www.firstfertilitypgs.co.th

WhatsApp & Mobile Phone: +66 63 269 2833

IG & Tiktok: firstfertilityconsultant

Email: center@firstfertilitypgs.co.th

Media Contact
Company Name: First Fertility PGS Center
Contact Person: Media Relations
Email: Send Email
Phone: +66 63 269 2833
City: Bangkok
Country: Thailand
Website: www.firstfertilitypgs.co.th

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: First Fertility PGS Center Limited Launches Indian Lounge

Intravenous Immunoglobulin Market Set for Substantial Growth Through 2034, Driven by Rising Disease Awareness and Innovative Pipeline Developments | DelveInsight

“Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2034”

The intravenous immunoglobulin market is experiencing robust expansion, driven by increasing disease awareness, rising prevalence of immunodeficiency disorders, and breakthrough therapeutic developments from key pharmaceutical players, including CSL Behring, Grifols, Octapharma, Kedrion, Takeda Pharmaceutical, Baxter International, ADMA Biologics, LFB Biotechnologies, Biotest AG, Shanghai RAAS Blood Products, China Biologics Products, BDI Pharma, and Intas Pharmaceuticals, among others.

DelveInsight’s “Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the intravenous immunoglobulin treatment landscape, historical and forecasted epidemiology, as well as market trends across the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. The report comprehensively evaluates current treatment practices, emerging drugs, market share of individual therapies, and intravenous immunoglobulin market forecasts through 2034, providing crucial insights for stakeholders in this critical therapeutic area.

According to DelveInsight’s analysis, the intravenous immunoglobulin market is poised for sustained growth driven by multiple factors, including the expanding understanding of disease mechanisms, technological advancements in plasma collection and manufacturing, and growing patient populations requiring immunoglobulin replacement therapy. The increasing burden of target diseases, such as primary immunodeficiency diseases, coupled with improved diagnostic capabilities, continues to drive market expansion.

Download the Intravenous Immunoglobulin Market report to understand which factors are driving the IVIG therapeutic market @ Intravenous Immunoglobulin Market Trends.

Intravenous Immunoglobulin Epidemiology

The DelveInsight report provides comprehensive epidemiological insights covering historical and current intravenous immunoglobulin patient pools with forecasted trends across individual countries within the 7MM. The analysis reveals significant regional variations in patient populations, with North America dominating the market, accounting for a significant portion of the total market share. The epidemiology segment explores the causes of current and forecasted trends through numerous studies and key opinion leader perspectives, providing diagnosed patient pool data and underlying assumptions.

The report categorizes patients requiring IVIG therapy across multiple indications, including primary immunodeficiency diseases, which represent the largest application segment, chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, Kawasaki disease, myasthenia gravis, and various autoimmune conditions. Primary immunodeficiency diseases account for the largest revenue share, with Kawasaki disease expected to exhibit the fastest growth during the forecast period.

Discover evolving trends in the Intravenous Immunoglobulin patient pool forecasts @ Intravenous Immunoglobulin Epidemiology Analysis.

Treatment Landscape and Pipeline Developments

The current intravenous immunoglobulin treatment landscape encompasses both marketed products and emerging therapies under late-stage development. The drug chapter segment provides a detailed analysis of IVIG marketed drugs and late-stage Phase II and Phase III pipeline candidates, including clinical trial details, pharmacological actions, regulatory milestones, and competitive advantages.

Recent pipeline developments highlight the dynamic nature of the IVIG market. Evolve Biologics recently completed its Phase III clinical trial for IVIG, with regulatory submission estimated for 2027, representing a significant advancement in plasma-derived therapeutics using proprietary PlasmaCap EBA purification technology.

The intravenous immunoglobulin pipeline analysis further reveals therapeutic candidates focusing on novel approaches to treat and improve disease conditions, with companies and academics working to assess challenges and opportunities that could influence IVIG research and development. Major pharmaceutical players, such as CSL Behring, Grifols, Octapharma, Kedrion, Takeda Pharmaceutical, Baxter International, ADMA Biologics, LFB Biotechnologies, Biotest AG, Shanghai RAAS Blood Products, China Biologics Products, BDI Pharma, and Intas Pharmaceuticals, are investing significantly in developing next-generation IVIG products with improved efficacy, safety profiles, and patient convenience.

Intravenous Immunoglobulin Market Access

The hospital pharmacies segment dominates the distribution landscape, while specialty pharmacies are expected to experience considerable growth over the forecast period. This shift reflects evolving healthcare delivery models and increased emphasis on specialized care for patients requiring immunoglobulin replacement therapy.

The report also addresses reimbursement scenarios across different markets, recognizing that proactive reimbursement strategies can significantly impact both late-stage product development and post-launch success. Understanding reimbursement landscapes helps identify economically attractive indications and market opportunities while selecting markets with fewer reimbursement barriers.

Discover recent advancements in the Intravenous Immunoglobulin treatment landscape @ Intravenous Immunoglobulin Recent Developments.

Conclusion

DelveInsight’s comprehensive analysis incorporates key opinion leader perspectives and primary research to validate market trends and treatment patterns, supporting clients in understanding the overall market scenario and unmet medical needs. The report’s competitive intelligence analysis utilizes various analytical tools, including SWOT analysis, PESTLE analysis, and Porter’s five forces, to provide strategic insights for market participants.

Looking ahead, the intravenous immunoglobulin market is expected to witness continued innovation driven by better disease understanding, novel therapeutic approaches, and significant investment from major players in developing targeted therapeutics. The launch of emerging therapies will significantly impact the IVIG market landscape, offering improved treatment options for patients with compromised immune systems while addressing current unmet medical needs.

DelveInsight’s analysis underscores that substantial opportunities remain for developing more effective and accessible treatment options, positioning the intravenous immunoglobulin market for remarkable expansion and therapeutic innovation in the coming decade.

Table of Contents

1. Intravenous Immunoglobulin Market Report Introduction

2. Executive Summary for Intravenous Immunoglobulin

3. SWOT analysis of Intravenous Immunoglobulin

4. Intravenous Immunoglobulin Patient Share (%) Overview at a Glance

5. Intravenous Immunoglobulin Market Overview at a Glance

6. Intravenous Immunoglobulin Disease Background and Overview

7. Intravenous Immunoglobulin Epidemiology and Patient Population

8. Country-Specific Patient Population of Intravenous Immunoglobulin

9. Intravenous Immunoglobulin Current Treatment and Medical Practices

10. Intravenous Immunoglobulin Unmet Needs

11. Intravenous Immunoglobulin Emerging Therapies

12. Intravenous Immunoglobulin Market Outlook

13. Country-Wise Intravenous Immunoglobulin Market Analysis (2019-2032)

14. Intravenous Immunoglobulin Market Access and Reimbursement of Therapies

15. Intravenous Immunoglobulin Market Drivers

16. Intravenous Immunoglobulin Market Barriers

17. Intravenous Immunoglobulin Appendix

18. Intravenous Immunoglobulin Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Intravenous Immunoglobulin Market Set for Substantial Growth Through 2034, Driven by Rising Disease Awareness and Innovative Pipeline Developments | DelveInsight

Chronic Spontaneous Urticaria Treatment Landscape Set for Transformation with Innovative Pipeline Therapies

“Chronic Spontaneous Urticaria – Pipeline Insight, 2025”

DelveInsight’s 2025 report highlights a dynamic pipeline for Chronic Spontaneous Urticaria, with major players like United BioPharma, Teva, Amgen, Novartis, Allakos, Sanofi, Celltrion, Celldex, MICROBIO GROUP, Escient, Jasper, Glenmark, Taiho, ValenzaBio, Carna Biosciences, and Servier advancing novel therapies across all development stages, aiming to meet significant unmet needs and transform the current treatment landscape.

DelveInsight’s “Chronic Spontaneous Urticaria – Pipeline Insight, 2025” report offers an in-depth analysis of over 20+ companies and their 20+ pipeline therapies targeting Chronic Spontaneous Urticaria. The report includes detailed profiles of both clinical and preclinical Chronic Spontaneous Urticaria drug candidates, along with a comprehensive evaluation based on product type, development stage, route of administration, and molecule type. Additionally, it sheds light on discontinued or inactive pipeline products in this domain.

The chronic spontaneous urticaria pipeline landscape is experiencing unprecedented activity, with over 20 companies developing more than 20 pipeline drugs across various stages of clinical development. This comprehensive pipeline encompasses late-stage products in Phase III, mid-stage products in Phase II, early-stage products in Phase I, along with preclinical and discovery stage candidates.

The pipeline drugs are categorized across multiple routes of administration, including intravenous, subcutaneous, oral, and intramuscular delivery systems. The therapeutic candidates span various molecule types, including monoclonal antibodies, small molecules, and peptides, representing diverse approaches to treating this challenging condition.

Download the Chronic Spontaneous Urticaria Pipeline Report for in-depth Chronic Spontaneous Urticaria competitive insights.

Advanced Pipeline Candidates in Late-Stage DevelopmentPhase III Clinical Trials

Remibrutinib (Novartis): This oral Bruton’s tyrosine kinase inhibitor has demonstrated significant long-term efficacy and safety in Phase III trials (REMIX-1 and REMIX-2). Novartis announced in July 2025 that a Phase 3b study is currently ongoing to assess efficacy, safety, and tolerability in comparison to placebo and omalizumab.

Rilzabrutinib (Sanofi): Another oral BTK inhibitor that showed positive results in the Phase II RILECSU study. This represents Sanofi’s continued investment in the BTK inhibitor pathway for chronic spontaneous urticaria treatment.

TLL-018 (Hangzhou Highlightll Pharmaceutical): Currently in Phase III development, this oral therapy is being evaluated in a multicenter, randomized, double-blind, placebo-controlled study involving participants with moderate-to-severe chronic spontaneous urticaria inadequately controlled by second-generation H1-antihistamines.

CT-P39 (Celltrion): A biosimilar to XOLAIR that has completed Phase III trials in January 2025, involving 619 patients with chronic spontaneous urticaria across six countries. The trial demonstrated bioequivalence to the reference product, with similar results in secondary endpoints of efficacy, pharmacokinetics, safety, and immunogenicity.

Phase II Development Programs

Tezepelumab (AstraZeneca/Amgen): A first-in-class monoclonal antibody inhibiting thymic stromal lymphopoietin has completed Phase II trials in the first quarter of 2025. Despite not meeting the primary endpoint at 16 weeks, the drug demonstrated delayed, sustained reductions in chronic spontaneous urticaria activity through week 32, particularly in anti-IgE therapy-naive patients.

Barzolvolimab (Celldex Therapeutics): In June 2025, Celldex Therapeutics Inc. (CLDX) reported promising Phase 2 Results for this humanized monoclonal antibody that specifically binds the receptor tyrosine kinase KIT. The drug demonstrated significant improvements in angioedema symptoms, with 77% of patients being angioedema-free at Week 52 and up to 87% reporting clinically meaningful improvement in angioedema activity scores.

Early-Stage and Novel Mechanisms

YH35324 (Yuhan Corporation): An IgE inhibitor designed based on IgE Trap-Fc fusion protein technology that has demonstrated positive results in Phase I clinical trials. The drug showed superior IgE reduction compared to existing therapies and demonstrated efficacy even in omalizumab-refractory patients, according to the study’s abstract published in June 2025.

Explore the Chronic Spontaneous Urticaria pipeline landscape and stay ahead with insights into the most promising chronic spontaneous urticaria therapies in development. Download the complete report now!

Current Treatment Paradigm and Emerging Alternatives

The current chronic spontaneous urticaria treatment paradigm follows a stepwise approach, beginning with second-generation H1-antihistamines as first-line therapy, followed by up-dosing to fourfold in refractory cases. For patients unresponsive to antihistamines, Roche/Novartis’s XOLAIR, a recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to IgE, remains the cornerstone therapy.

The recent approval of Sanofi/Regeneron’s DUPIXENT by the FDA in April 2025 for chronic spontaneous urticaria patients aged 12 years and older introduces a valuable alternative mechanism targeting IL-4 and IL-13 signaling pathways. This marks the first new targeted therapy in over a decade for chronic spontaneous urticaria.

Furthermore, in March 2025, Celltrion secured FDA approval for OMLYCLO (omalizumab-igec) as the first interchangeable biosimilar to XOLAIR, potentially improving treatment access and affordability.

Discover evolving trends in the Chronic Spontaneous Urticaria treatment landscape @ Chronic Spontaneous Urticaria Recent Developments.

Addressing Unmet Medical Needs

Despite therapeutic advances, significant challenges persist in chronic spontaneous urticaria management. Nearly one-third of patients remain symptomatic despite omalizumab treatment, and the subcutaneous administration route creates an additional burden for healthcare systems and patients. The high cost of biologics limits accessibility, particularly in restricted healthcare environments where more affordable options like H2-antagonists and dapsone maintain relevance despite not being included in formal treatment guidelines.

The comprehensive pipeline addressing these unmet needs includes oral BTK inhibitors that offer convenient administration, novel anti-IgE therapies with enhanced mechanisms of action, and upstream-targeted therapies that inhibit multiple pathways. These innovations highlight the importance of continued research and development in creating cost-effective, convenient, and efficacious treatments for this challenging dermatological condition.

As the understanding of chronic spontaneous urticaria pathophysiology continues to evolve, the treatment landscape is expected to transform dramatically with novel therapies addressing the significant unmet needs in this condition. The robust pipeline of over 20 companies developing diverse therapeutic approaches represents a promising future for patients suffering from this debilitating condition.

Table of Contents

1. Introduction

2. Executive Summary

3. Chronic Spontaneous Urticaria: Overview

4. Pipeline Therapeutics

5. Therapeutic Assessment

6. Chronic Spontaneous Urticaria– DelveInsight’s Analytical Perspective

7. Late-Stage Products (Preregistration)

8. Late-Stage Products (Phase III)

9. Mid-Stage Products (Phase II)

10. Early Stage Products (Phase I)

11. Preclinical and Discovery Stage Products

12. Inactive Products

13. Chronic Spontaneous Urticaria Key Companies

14. Chronic Spontaneous Urticaria Key Products

15. Chronic Spontaneous Urticaria- Unmet Needs

16. Chronic Spontaneous Urticaria- Market Drivers and Barriers

17. Chronic Spontaneous Urticaria- Future Perspectives and Conclusion

18. Chronic Spontaneous Urticaria Analyst Views

19. Chronic Spontaneous Urticaria Key Companies

20. Appendix

DelveInsight’s Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast report offers a comprehensive analysis of Chronic Spontaneous Urticaria market, including detailed insights into its historical and projected Chronic Spontaneous Urticaria epidemiological trends and evolving treatment landscape across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.

About DelveInsight

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Spontaneous Urticaria Treatment Landscape Set for Transformation with Innovative Pipeline Therapies

Guestpostforyou Levels the SEO Playing Field with Low-Cost Guest Posting Solutions

In today’s increasingly competitive digital landscape, SEO has become a core pillar of online growth—especially for agencies and small businesses aiming to boost visibility without breaking the bank. One area gaining rapid traction is the rise of affordable guest posting packages, which offer scalable backlink strategies while maintaining quality.

A Shift Toward Scalable Off-Page SEO

Search engines continue to reward authoritative content and high-quality backlinks. However, traditional outreach can be time-consuming, inconsistent, and expensive. That’s where services like Guest Post For You have stepped in—offering agencies access to a curated network of real, traffic-verified websites across hundreds of niches.

Their affordable guest posting packages are tailored to meet the needs of small teams, solopreneurs, and scaling SEO firms alike. With guaranteed placement, SEO-optimized content, and transparent pricing, this approach is helping level the playing field for those without massive marketing budgets.

Blogger Outreach Still Matters — If Done Right

Another essential component of link building is blogger outreach, a process that involves finding relevant blogs, pitching quality content, and securing authentic backlinks. But as outreach has become more saturated, strategy matters more than ever. This guide on Medium outlines key steps and best practices for effective blogger outreach in 2025, from research to relationship-building.

When done right, blogger outreach builds more than links—it builds trust, traffic, and long-term partnerships with niche-relevant audiences.

The Takeaway

As Google’s algorithms continue to reward real value over link spam, agencies are shifting toward quality-driven, ethical link-building strategies. Platforms offering affordable guest posting packages and data-driven blogger outreach are becoming essential tools—not just for SEO results, but for overall brand growth.

For agencies and businesses ready to scale without sacrificing quality, the right outreach partner can make all the difference.

Media Contact

Contact Person: Jamshaid Ali

Company: Guestpostforyou

Email: info@guestpostforyou.com

Website: https://guestpostforyou.com/

Address: International House, 10 Churchill Way, Cardiff, CF10 2HE

Media Contact
Company Name: Guestpostforyou
Contact Person: Jamshaid Ali
Email: Send Email
Address:International House, 10 Churchill Way
City: Cardiff, CF10 2HE
Country: United Kingdom
Website: https://guestpostforyou.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Guestpostforyou Levels the SEO Playing Field with Low-Cost Guest Posting Solutions